Market Cap: $9.53M
SI
Skye Bioscience, Inc.
SKYE
NASDAQUSD
Market Cap: $9.53M
Skye Bioscience Gears Up for Key Quarterly Earnings Report Amidst Impactful Advances in Biotech As Skye Bioscience prepares to release its quarterly earnings report on March 10, 2026, the focus intens…
Skye Bioscience Gears Up for Quarterly Earnings Amid Growing Focus on Cannabis-Derived Treatments Skye Bioscience, a biotechnology firm, is set to release its latest quarterly earnings report on March…
Skye Bioscience Faces Legal Challenges Over Drug Efficacy Claims Skye Bioscience, Inc. confronts significant legal scrutiny as the Schall Law Firm and DJS Law Group announce class action lawsuits agai…
Skye Bioscience Faces Class Action Lawsuits Amid Allegations of Misleading Statements Skye Bioscience, Inc. is currently embroiled in legal challenges as two separate law firms announce class action l…
Skye Bioscience Faces Class Action Lawsuit Over Drug Misrepresentation Recent developments surrounding Skye Bioscience, Inc. (NASDAQ: SKYE) highlight a class action lawsuit initiated by Rosen Law Firm…
Skye Bioscience Faces Class Action Lawsuit Over Misleading Claims In a significant development for Skye Bioscience, Inc., shareholders are urged to participate in a class action lawsuit spearheaded by…
Skye Bioscience Faces Class Action Over Misleading Drug Claims Skye Bioscience, Inc. is embroiled in a class action lawsuit filed by national plaintiffs' law firm Berger Montague PC, alleging that the…
Skye Bioscience Faces Legal Challenges Over Nimacimab Claims Skye Bioscience, Inc. is currently embroiled in a class action lawsuit initiated by investors who claim the company made misleading stateme…
Skye Bioscience Faces Class Action Lawsuit Over Misleading Product Claims Skye Bioscience, Inc. is currently under scrutiny as Rosen Law Firm announces a critical deadline for investors affected by al…
Skye Bioscience Faces Class Action Lawsuit Over Alleged Misrepresentation of Nimacimab Skye Bioscience, Inc. is currently embroiled in a class action securities lawsuit filed by Levi & Korsinsky, LLP.…
Skye Bioscience Faces Legal Scrutiny Over Nimacimab Allegations Skye Bioscience, Inc., a biotechnology firm focused on developing cannabinoid-based therapies, is currently under investigation due to a…
Skye Bioscience Partners with Halozyme to Advance Obesity Treatment Skye Bioscience, Inc. has entered into a significant global collaboration with Halozyme Therapeutics to leverage the ENHANZE® drug d…
Skye Bioscience Partners with Halozyme to Advance Obesity Treatment Skye Bioscience, Inc. has entered into a significant collaboration with Halozyme Therapeutics, Inc. to leverage the latter’s ENHANZE…
Legal Challenges Loom for Skye Bioscience Amid Allegations of Misleading Information In a significant development for Skye Bioscience, Inc. (NASDAQ: SKYE), Levi & Korsinsky, LLP has initiated a class…
### Legal Action Highlights Accountability in Biopharmaceutical Sector Skye Bioscience, Inc., a company specializing in developing therapeutic solutions, faces two class action lawsuits from prominent…
Legal Challenges Loom for Skye Bioscience Amid Allegations of Misleading Statements Skye Bioscience, Inc. (NASDAQ: SKYE) faces significant legal scrutiny as Levi & Korsinsky, LLP announces a class act…
Skye Bioscience Faces Class Action Lawsuit Over Product Misrepresentation Skye Bioscience, Inc. is embroiled in legal turmoil following a class action lawsuit filed by the DJS Law Group, claiming the…
Skye Bioscience Faces Class Action Lawsuit Over Alleged Misleading Statements Skye Bioscience, Inc. (NASDAQ: SKYE) is currently at the center of a class action lawsuit initiated by the DJS Law Group,…
Skye Bioscience Faces Class Action Lawsuit Over Alleged Misrepresentation Recent developments surrounding Skye Bioscience, Inc. (NASDAQ: SKYE) spotlight serious allegations regarding the company’s lea…
Skye Bioscience Faces Class Action Lawsuits Over Drug Misrepresentations In a significant development for Skye Bioscience, Inc. (NASDAQ: SKYE), two prominent law firms have initiated class action laws…
Skye Bioscience Faces Class Action Lawsuit Over Nimacimab Claims Skye Bioscience, Inc. is currently embroiled in a class action securities lawsuit initiated by Levi & Korsinsky, LLP, a law firm known…
Legal Scrutiny Surrounds Skye Bioscience Over Nimacimab Claims In a significant development for Skye Bioscience, Inc., the Gross Law Firm has issued a notice to shareholders concerning a potential cla…
Skye Bioscience Faces Class Action Lawsuits Over Nimacimab Claims In a significant legal development, Skye Bioscience, Inc. is currently facing multiple class action lawsuits stemming from allegations…
Legal Action Looms for Skye Bioscience Investors Amid Drug Efficacy Allegations In a significant development for Skye Bioscience, Inc., renowned global investor rights law firm Rosen Law Firm has issu…
Legal Challenges Loom for Skye Bioscience Amid Allegations of Securities Fraud Skye Bioscience, Inc. (NASDAQ: SKYE) faces significant legal challenges as a class action securities lawsuit is filed aga…